Position in MRK
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$3,768,776
+$252,219 QoQ
Shares Held
29,329
+0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,186
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHILTON CAPITAL MANAGEMENT LLC holds $189,707,778 across 12 Drug Manufacturers - General names. MRK ranks #5 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
69,286 | $83,103,713 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
411,727 | $52,017,589 | |
| 3 | AZN |
Astrazeneca PLC
|
201,189 | $38,149,458 | |
| 4 | JNJ |
Johnson & Johnson
|
21,048 | $5,345,560 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
29,329 | $3,768,776 | |
| 6 | ABBV |
AbbVie Inc.
|
13,608 | $3,424,317 | |
| 7 | AMGN |
Amgen Inc
|
4,095 | $1,482,881 | |
| 8 | NVS |
Novartis AG
|
7,290 | $1,142,488 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,768,776 | 29,329 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $3,516,557 | 29,234 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,068,223 | 29,149 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,577,490 | 30,710 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $2,383,903 | 30,115 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,831,120 | 31,541 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $7,905,377 | 79,467 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $32,942,506 | 290,089 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $33,188,923 | 268,085 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $33,226,857 | 251,814 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $26,493,277 | 243,013 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $3,682,521 | 35,770 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,115,384 | 35,665 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,676,093 | 34,553 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $3,733,467 | 33,650 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,269,804 | 37,968 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,483,970 | 38,214 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $3,163,437 | 38,555 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,276,053 | 42,746 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,293,273 | 43,846 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $3,399,560 | 43,713 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,998,571 | 38,897 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,177,274 | 38,842 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,221,945 | 38,842 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,204,369 | 28,506 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $2,243,261 | 29,156 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||